Literature DB >> 21669035

Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression.

Johan Lundberg1, Erik Södersten, Erik Sundström, Katarina Le Blanc, Tommy Andersson, Ola Hermanson, Staffan Holmin.   

Abstract

Stem cell transplantation procedures using intraparenchymal injections cause tissue injury in addition to associated surgical risks. Intravenous cell administration give engraftment in parenchymal lesions although the method has low efficacy and specificity. In pathological conditions with inflammation, such as traumatic brain injury, there is a transient up-regulation of ICAM-1 and VCAM-1 which might provide environmental cues for migration of stem cells from blood to parenchyma. The aim of this study was to i) analyze the effect of intra-arterial administration on cellular engraftment, ii) compare engraftment and side effects between three different stem cell systems, and iii) analyze gene expression in these three systems. We performed specific intra-arterial transplantations with human mesenchymal stem cells (hMSCs), human neural progenitor cells (hNPCs), and rat neural progenitor cells (rNPCs) in a rat model of traumatic brain injury. These results were compared to the intravenous route for each cell type, respectively. Analysis of engraftment and recipient characterization was performed by immunohistochemistry. We further characterized the different types of cells by microarray and RT-qPCR analysis. Specific intra-arterial transplantations produced significantly higher engraftment compared to intravenous transplantation with hMSCs and rNPCs. No engraftment was detected after intra-arterial or intravenous administration of hNPCs. Characterization of integrin expression indicated that CD49dVCAM-1 and possibly ICAM-1 interactions through CD18 and CD11a, respectively, are important for engraftment after intravascular cell administration. No side effects, such as thromboembolic complications, were detected. When translating stem cell therapies to clinical practice, the route of transplantation and the properties of the cell lines (homing, diapedesis, and migration) become important. This study supports the use of selective intra-arterial transplantation for improving engraftment after traumatic brain injury. In addition, we conclude that careful analysis of cells intended for local, intra-arterial transplantation with respect to integrin expression is important.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669035     DOI: 10.3727/096368911X576036

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  16 in total

1.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

2.  Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.

Authors:  Xuegang Yuan; Jens T Rosenberg; Yijun Liu; Samuel C Grant; Teng Ma
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

3.  Amelioration of Penetrating Ballistic-Like Brain Injury Induced Cognitive Deficits after Neuronal Differentiation of Transplanted Human Neural Stem Cells.

Authors:  Markus S Spurlock; Aminul I Ahmed; Karla N Rivera; Shoji Yokobori; Stephanie W Lee; Pingdewinde N Sam; Deborah A Shear; Michael P Hefferan; Thomas G Hazel; Karl K Johe; Shyam Gajavelli; Frank C Tortella; Ross M Bullock
Journal:  J Neurotrauma       Date:  2017-03-23       Impact factor: 5.269

Review 4.  Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?

Authors:  Robin Lemmens; Gary K Steinberg
Journal:  Curr Opin Neurol       Date:  2013-12       Impact factor: 5.710

5.  Long term follow-up of the endovascular trans-vessel wall technique for parenchymal access in rabbit with full clinical integration.

Authors:  Johan Lundberg; Stefan Jonsson; Staffan Holmin
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

6.  Will Stem Cell Open up the New Realms of Neurointervention?

Authors:  Chang-Woo Ryu
Journal:  Neurointervention       Date:  2011-08-31

7.  The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity.

Authors:  Li-li Cui; Erja Kerkelä; Abdulhameed Bakreen; Franziska Nitzsche; Anna Andrzejewska; Adam Nowakowski; Miroslaw Janowski; Piotr Walczak; Johannes Boltze; Barbara Lukomska; Jukka Jolkkonen
Journal:  Stem Cell Res Ther       Date:  2015-01-27       Impact factor: 6.832

8.  A novel method for efficient delivery of stem cells to the ischemic brain.

Authors:  Ling Guo; Jianfeng Ge; Shan Wang; Ying Zhou; Xiaoxiao Wang; Yaojiong Wu
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

9.  MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications.

Authors:  Nabid Ahmed; Dheeraj Gandhi; Elias R Melhem; Victor Frenkel
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.086

10.  Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro Study.

Authors:  Li-Li Cui; Tuure Kinnunen; Johannes Boltze; Johanna Nystedt; Jukka Jolkkonen
Journal:  Stem Cells Int       Date:  2016-02-28       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.